medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2026; 35 (1)

DRESS syndrome in a pediatric patient: an infrequent diagnosis with high morbidity and mortality

Morales PEJ, Mejía LA, Jiménez PEN, Muñoz PLE, Sandoval SF
Full text How to cite this article 10.35366/123527

DOI

DOI: 10.35366/123527
URL: https://dx.doi.org/10.35366/123527

Language: Spanish
References: 7
Page: 11-15
PDF size: 1946.91 Kb.


Key words:

DRESS syndrome, eosinophilia, drug-induced dermatitis, allopurinol, pediatrics.

ABSTRACT

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe, uncommon, and potentially life-threatening delayed hypersensitivity reaction associated with exposure to various medications. It is characterized by extensive cutaneous rash, fever, hematologic abnormalities, and possible systemic involvement, which makes early recognition challenging, particularly in the pediatric population. We report the case of a 16-year-old male patient with a history of chronic kidney disease who developed rapidly progressive cutaneous erythema, mucocutaneous involvement, and fever following the recent initiation of allopurinol. Laboratory studies revealed eosinophilia and leukopenia. The diagnosis was established based on clinical and laboratory findings using the RegiSCAR criteria, classifying the case as possible DRESS syndrome, with histopathological confirmation obtained through skin biopsy. The suspected drug was discontinued, and treatment with systemic corticosteroids and intravenous immunoglobulin was initiated, resulting in favorable clinical evolution without evidence of systemic organ involvement. This case highlights the importance of early recognition and multidisciplinary management to improve patient outcomes.


REFERENCES

  1. Gómez CMT, Corrales MTM, Ugalde JO. Síndrome de DRESS: abordaje diagnóstico y terapéutico. Revista Médica Sinergia. 2019; 4 (6): 60-72. Disponible en: https://doi.org/10.31434/rms.v4i6.244

  2. Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: a literature review and treatment algorithm. World Allergy Organ J. 2023; 16 (3): 100673.

  3. Muciño MEY, Ortiz PTA, Ocaña UGG, Vásconez MRG. Toxicodermias graves: síndrome de DRESS. RECIMUNDO. 2022; 6 (4): 214-223. Disponible en: https://doi.org/10.26820/recimundo/6.(4).octubre.2022.214-223

  4. Kuyucu S, Blanca-Lopez N, Caubet JC, Moral L, Sousa-Pinto B, Topal OY et al. Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: an EAACI position paper. Pediatr Allergy Immunol. 2025; 36 (7): e70103.

  5. Silva-Tirado MP. Síndrome DRESS. Med Interna Méx. 2019; 35 (2): 325-331. Disponible en: https://doi.org/10.24245/mim.v35i2.2267

  6. Lagrutta L, Gamberale A, Bartoletti B, Rodríguez MA, Failde R, Bornengo F et al. Síndrome DRESS por fármacos antituberculosis. Revisión y comentarios. Medicina (B. Aires). 2025; 85 (3): 572-585.

  7. Sotelo-Barajas B, Elizalde-Morán N, Félix-Ramos G, Contrera-Navarro N. Síndrome de DRESS: otro gran imitador en urgencias pediátricas. Bol Clin Hosp Infant Edo Son. 2025; 42 (1): 44-49.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2026;35